Masakazu Tanaka, Norihiro Takenouchi, Shiho Arishima, Toshio Matsuzaki, Satoshi Nozuma, Eiji Matsuura, Hiroshi Takashima, Ryuji Kubota. HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load. International journal of molecular sciences. 2024. 25. 13
Tomoo Sato, Masahiro Nagai, Osamu Watanabe, Tatsuro Misu, Norihiro Takenouchi, Ryuichi Ohkubo, Satoshi Ishihara, Yoshio Tsuboi, Masahisa Katsuno, Masanori Nakagawa, et al. Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy. Journal of neurology. 2024. 271. 6. 3471-3485
Shin Iida, Masataka Nakamura, Kumi Itani, Satoshi Morise, Takenobu Kunieda, Norihiro Takenouchi, Satoshi Kaneko, Yusuke Yakushiji. Quantitative and Morphological Assessment of Computed Tomography-depicted Gynecomastia in Spinal and Bulbar Muscular Atrophy. Academic radiology. 2022. 29. 11. 1692-1699
Rie Tohge, Satoshi Kaneko, Satoshi Morise, Mitsuaki Oki, Norihiro Takenouchi, Aya Murakami, Masataka Nakamura, Hirofumi Kusaka, Yusuke Yakushiji. Zonisamide attenuates the severity of levodopa-induced dyskinesia via modulation of the striatal serotonergic system in a rat model of Parkinson's disease. Neuropharmacology. 2021. 198. 108771-108771
Kumi Itani, Masataka Nakamura, Reika Wate, Satoshi Kaneko, Kengo Fujita, Shin Iida, Satoshi Morise, Aya Murakami, Takenobu Kunieda, Norihiro Takenouchi, et al. Efficacy and safety of tacrolimus as long-term monotherapy for myasthenia gravis. Neuromuscular disorders : NMD. 2021. 31. 6. 512-518